Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Major Shareholding Notification 2021

Apr 13, 2021

5250_rns_2021-04-13_e6ac9b40-d3e2-48db-880e-1f5dcfa26226.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

Form 8.3 - WILLIS TOWERS WATSON PLC AMENDMENT

Ap19

FORM 8.3 Amendment to purchase

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 09 April 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,675,641 1.30% 190,397 0.15%
(2) Derivatives (other than options):
102,359 0.08% 7,100 0.01%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,784,100 1.38% 203,597 0.16%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 5 238.8900 USD
Purchase 18 238.9700 USD
Purchase 27 239.4400 USD
Purchase 33 239.4500 USD
Purchase 36 237.2280 USD
Purchase 40 239.3900 USD
Purchase 43 239.9000 USD
Purchase 100 238.8100 USD
Purchase 100 237.6100 USD
Purchase 150 239.3816 USD
Purchase 171 239.2194 USD
Purchase 200 238.6450 USD
Purchase 632 238.0700 USD
Purchase 953 239.2677 USD
Purchase 2,507 238.9603 USD
Purchase 2,980 239.4197 USD
Purchase 3,276 239.1303 USD
Purchase 3,457 239.1485 USD
Purchase 5,702 238.9753 USD
Purchase 6,851 239.8577 USD
Purchase 9,193 239.3118 USD
Purchase 13,694 239.9800 USD
Sale 6 239.1000 USD
Sale 6 239.0600 USD
Sale 6 239.1850 USD
Sale 12 239.5475 USD
Sale 18 239.1133 USD
Sale 20 239.5140 USD
Sale 30 239.1110 USD
Sale 36 239.0050 USD
Sale 39 239.9600 USD
Sale 50 239.2850 USD
Sale 54 237.2280 USD
Sale 100 238.9100 USD
Sale 100 238.4800 USD
Sale 100 237.6600 USD
Sale 100 238.9300 USD
Sale 100 239.8700 USD
Sale 105 238.8900 USD
Sale 140 239.0400 USD
Sale 159 238.9574 USD
Sale 185 239.1197 USD
Sale 200 238.0700 USD
Sale 300 239.8833 USD
Sale 300 239.3813 USD
Sale 303 239.9686 USD
Sale 500 238.9907 USD
Sale 500 239.1680 USD
Sale 746 239.5893 USD
Sale 1,055 239.3201 USD
Sale 1,100 238.4836 USD
Sale 1,176 239.5855 USD
Sale 1,299 238.9459 USD
Sale 1,848 238.8966 USD
Sale 2,414 239.0766 USD
Sale 2,776 239.1235 USD
Sale 4,323 239.0935 USD
Sale 4,741 239.5782 USD
Sale 5,655 239.0961 USD
Sale 6,851 239.8577 USD
Sale 11,843 239.9800 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 13 Apr 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210413005806/en/

BARCLAYS PLC